These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16880571)

  • 1. The efficacy of 1% metronidazole gel in facial seborrheic dermatitis: a double blind study.
    Siadat AH; Iraji F; Shahmoradi Z; Enshaieh S; Taheri A
    Indian J Dermatol Venereol Leprol; 2006; 72(4):266-9. PubMed ID: 16880571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is topical metronidazole effective in seborrheic dermatitis? A double-blind study.
    Koca R; Altinyazar HC; Eştürk E
    Int J Dermatol; 2003 Aug; 42(8):632-5. PubMed ID: 12890109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical metronidazole in seborrheic dermatitis--a double-blind study.
    Parsad D; Pandhi R; Negi KS; Kumar B
    Dermatology; 2001; 202(1):35-7. PubMed ID: 11244226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C; Ferrari A
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study.
    Ozcan H; Seyhan M; Yologlu S
    Eur J Dermatol; 2007; 17(4):313-6. PubMed ID: 17540638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
    Chosidow O; Maurette C; Dupuy P
    Dermatology; 2003; 206(3):233-40. PubMed ID: 12673081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind study of the effectiveness of sertaconazole 2% cream vs. metronidazole 1% gel in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Raghifar R
    Ann Parasitol; 2013; 59(4):173-7. PubMed ID: 24791343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclopirox gel for seborrheic dermatitis of the scalp.
    Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults.
    Papp KA; Papp A; Dahmer B; Clark CS
    J Am Acad Dermatol; 2012 Jul; 67(1):e11-5. PubMed ID: 22101215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis.
    Piérard-Franchimont C; Piérard GE
    Dermatology; 2002; 204(4):344-7. PubMed ID: 12077544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
    Cicek D; Kandi B; Bakar S; Turgut D
    J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
    Abeck D;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of terbinafine 1% cream on seborrhoeic dermatitis.
    Gündüz K; Inanir I; Sacar H
    J Dermatol; 2005 Jan; 32(1):22-5. PubMed ID: 15841656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis.
    Zhao J; Sun W; Zhang C; Wu J; Le Y; Huang C; Liu Y; Xiang L
    J Cosmet Dermatol; 2018 Feb; 17(1):90-94. PubMed ID: 28589618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial.
    Firooz A; Solhpour A; Gorouhi F; Daneshpazhooh M; Balighi K; Farsinejad K; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Aug; 142(8):1066-7. PubMed ID: 16924062
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study.
    Shemer A; Kaplan B; Nathansohn N; Grunwald MH; Amichai B; Trau H
    Isr Med Assoc J; 2008 Jun; 10(6):417-8. PubMed ID: 18669136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.